Bendamustine pharmaceutical compositions for lyophilisation

Details for Australian Patent Application No. 2006204817 (hide)

Owner Cephalon, Inc.

Inventors Brittain, Jason Edward; Franklin, Joe Craig

Agent Watermark

Pub. Number AU-B-2006204817

PCT Pub. Number WO2006/076620

Priority 11/330,868 12.01.06 US; 60/644,354 14.01.05 US

Filing date 13 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 25 November 2010

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/4184 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076620 Priority application(s): WO2006/076620

25 November 2010 Application Accepted

  Published as AU-B-2006204817

23 December 2010 Amendment Made

  The nature of the amendment is: Amend invention title to read Bendamustine pharmaceutical compositions

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204834-Knowledge determination system

2006204813-Security features, their use, and processes for making them